Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL — Stella

Recruiting

Back to Aphakia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

France

Clinique Honore Cave, Montauban

West Ophta, Rennes

Key details

Sponsor

Cutting Edge SAS

Enrollment target

~58 participants

Started

October 2024

Primary completion

December 2026

Age range

50 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov